Medication info

Acyclovir Tablet (Acyclovir)

Prescription medicationTabletIntravenous injectionExpired
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Hanpung Pharmaceutical Co., Ltd.
Appearance
Light blue round tablet
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Expired

MFDS item code 201905658 · Approved 2019.08.12

This product's status changed to Expired on 2024.08.12. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of herpes simplex (e.g., genital herpes); treatment of herpes zoster and chickenpox
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg 5 times daily at 4-hour intervals for 5 days. In severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; in recurrent cases, administration is preferably started when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, treatment should be periodically discontinued for patients receiving long-term treatment every 6 ~ 12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal absorption disorders. 3) It is best to start treatment as soon as possible after infection; the earlier the treatment, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more prone to adverse neuropsychiatric reactions; use caution, for example, by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg of this drug twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg of this drug 3 times daily at approximately 8-hour intervals.
Child administration
1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Age 2 years and older: Same as the adult dosage. 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Under 2 years of age: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older — Children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Ingredients

Manufacturer
Hanpung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex (e.g., genital herpes); treatment of herpes zoster and chickenpox

  • Genital herpes
  • herpes simplex virus infections of the skin and mucosal tissue
  • herpes zoster virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is effective in the treatment and prevention of infections caused by the herpes simplex virus, including primary and recurrent genital herpes. It also aids in the treatment of herpes zoster virus infections, particularly in alleviating acute pain. It is used for treating chickenpox and can be applied to children over 2 years of age. However, the effectiveness for post-herpetic neuralgia has not yet been definitively proven. Overall, this medication is widely used for the treatment of various viral skin and mucosal infections.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg 5 times daily at 4-hour intervals for 5 days. In severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; in recurrent cases, administration is preferably started when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, treatment should be periodically discontinued for patients receiving long-term treatment every 6 ~ 12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal absorption disorders. 3) It is best to start treatment as soon as possible after infection; the earlier the treatment, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more prone to adverse neuropsychiatric reactions; use caution, for example, by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg of this drug twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg of this drug 3 times daily at approximately 8-hour intervals.

Child administration

1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Age 2 years and older: Same as the adult dosage. 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Under 2 years of age: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older — Children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Precautions

This medication should not be used in patients who have had allergic reactions to this medication, its components, or valacyclovir. Patients with impaired kidney function may experience more side effects, so caution is advised when using this medication. Patients with compromised liver function should also be administered this medication with care, as their liver function may worsen. Extra caution is required for children and infants, and elderly patients are also at higher risk of renal impairment and adverse reactions, necessitating careful monitoring. Severe allergic reactions, such as anaphylactic shock, may rarely occur; thus, if symptoms like low blood pressure, difficulty breathing, or chest tightness occur during administration, stop the treatment immediately and seek appropriate treatment. Skin rashes, fever, blisters, and hives may appear, and in severe cases, serious skin conditions such as Stevens-Johnson syndrome or Lyell syndrome may develop, requiring cessation of treatment upon symptom onset. Symptoms of a mental or neurological nature can include altered consciousness, confusion, hallucinations, seizures, drowsiness, and anxiety; these symptoms may be more frequent in the elderly or those with reduced kidney function. Kidney problems may arise, with symptoms such as renal failure, hematuria, and proteinuria, so it is important to periodically check kidney function. Blood-related abnormalities can manifest as leukopenia, anemia, bleeding, and purpura; notify healthcare providers immediately if such symptoms occur. Liver dysfunction or symptoms of jaundice or hepatitis may appear, necessitating observation for symptoms along with liver function tests. Gastrointestinal symptoms may include gastritis, nausea, vomiting, abdominal pain, and diarrhea, and treatment should be stopped if symptoms are severe. Adequate hydration is necessary while taking this medication, and preventing dehydration is particularly important during high-dose administration. This medication is most effective when given early in the course of illness, so treatment should begin as soon as symptoms appear. Pregnant women or those who may become pregnant should consult a physician regarding the use of this medication, as it may affect the fetus. Lactating women should discontinue breastfeeding during treatment since this medication’s components may pass into breast milk. Overdosage can result in kidney damage and central nervous system symptoms, and therefore, dosage should be strictly adhered to, with immediate contact with a medical facility in the event of overdose. This medication may interact with other drugs; therefore, inform healthcare providers of any concomitant medications.

Side effects

  • Anaphylactic shock
  • anaphylactoid reactions
  • hypotension
  • respiratory distress
  • chest tightness
  • photosensitivity reactions
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 122 more
  • urticaria-like erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration disturbances
  • aggressive behavior
  • depersonalization
  • anxiety
  • impaired coordination
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • talking to oneself
  • abnormal sensations
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • increased serum creatinine
  • hematuria
  • proteinuria
  • red blood cell casts in urine
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • elevated LDH
  • elevated ALP
  • increased total bilirubin
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • general malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • increased blood pressure
  • decreased blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • alopecia
  • sweating
  • hyponatremia
  • decreased serum protein
  • elevated total cholesterol
  • elevated triglycerides
  • increased serum potassium
  • decreased serum albumin
  • anxiety
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • seizure disorders
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to ensure the effectiveness and safety of the medication.

Appearance and packaging

Appearance

Light blue round tablet

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.